The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most rapid benefit seen in ...

Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 millionReceived CE Mark for LungFit PH® in ...

Ethiopia has officially launched the country’s securities exchange (ESX) at an event officiated by Prime Minister Dr. Abiy Ahmed on Friday last week. The exchange, established by the country’s ...

The Securities and Exchange Commission (SEC) envisions a greener, low-carbon and sustainable economy by fostering ...

The Securities and Exchange Commission (SEC) is accelerating its push for sustainable finance in the Philippines, ...

Ubiquiti Inc. (NYSE: UI) ("Ubiquiti" or the "Company") today announced its financial results for the second quarter ended December 31, 2024. Second Quarter Fiscal 2025 ...

Free Cash Flow1: Free cash flow was $380.0 million for the fourth quarter of 2024, compared to $164.8 million for the same ...

Google parent company Alphabet has stopped making diversity and inclusion a workplace priority, according to a filing ...

Fourth Quarter and Full Year 2024 Net Product Sales of $615 Million and $2.3 Billion, Representing Year-Over-Year Growth of 23% and 26% Respectively INGREZZA® (valbenazine) Full Year 2025 Net Product ...

Digital initiatives made doing business in the country more efficient and propelled the number of new companies registered with the Securities and Exchange Commission (SEC) to an all-time high last ...

Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...

Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.